QUOTE AND NEWS
Benzinga  Sep 24  Comment 
In a report published Tuesday, J.P. Morgan analyst James D. Gordon downgraded the rating on Prosensa Holding NV (NASDAQ: RNA) from Overweight to Neutral, and lowered the price target from $35.00 to $6.50. In the report, J.P. Morgan noted,...
Benzinga  Jun 17  Comment 
In a report published Monday, Credit Suisse analyst Jason Kantor initiated coverage on Portola Pharmaceuticals (NASDAQ: PTLA) with an Outperform rating and $30.00 price target. In the report, Credit Suisse noted, “We are initiating coverage...
Benzinga  Jun 12  Comment 
In a report published Wednesday, Sterne Agee analyst Greg T. Bolan resumed coverage on ICON (NASDAQ: ICLR) with a Neutral rating and $34.00 price target. In the report, Sterne Agee noted, “Given ICON's ‘pure-play' status as a late stage...
Benzinga  Jan 24  Comment 
Morgan Keegan has published a research report following a positive notification from the data safety monitoring board that has given Baxter International, Inc. (NYSE: BAX) the go-ahead to initiate a second Phase III study. “We view the...
StreetInsider.com  Jul 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharmaceuticals+%28LGND%29+Partner+GlaxoSmithKline+%28GSK%29+Receives+Positive+Data+from+Promacta+PIII+ENABLE1+Study+/6658594.html for the full story.
FierceBiotech  Oct 20  Comment 
A trio of venture capital firms has chipped in $24 million to fund a new biotech company, which is starting out with a late-stage development program licensed in from Unigene Laboratories. Unigene gets a 25 percent stake in the company and a...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki